Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T2C Regimen and Radiation for Malignant Gliomas
NCT00492687Phase 2Unknown
- Sponsor
- San Diego Pacific Oncology & Hematology Associates
- Start
- Dec 2006
- Primary completion
- Jul 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, tamoxifen, carboplatin in malignant glioma, glioblastoma multiforme (GBM), anaplastic astrocytoma (AA), sponsored by San Diego Pacific Oncology & Hematology Associates. Status: unknown.
02
Drugs
temozolomidetamoxifencarboplatin
03
Conditions
malignant gliomaglioblastoma multiforme (GBM)anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT00492687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492687.